Many transcription factors are known, or are inferred, to bind to the HML-2 5′ LTR [49], e.g. expression of the 22q11.23 (H22q) provirus – the potential prostate cancer biomarker mentioned above – has been shown to be regulated by androgens via its androgen receptor binding site [41]. Here, AR is linked to prostate carcinoma.